These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 3395402)
1. Pharmacokinetics of graded single doses of the novel antitussive compound vadocaine hydrochloride in healthy male volunteers. Karttunen P; Männistö PT; Tukiainen H; Uusitupa M; Nissinen E Arzneimittelforschung; 1988 Apr; 38(4A):635-8. PubMed ID: 3395402 [TBL] [Abstract][Full Text] [Related]
2. The single dose and steady-state pharmacokinetics of a vadocaine tablet in healthy human volunteers. Silvasti M; Karttunen P; Tukiainen H; Mykkänen M; Hänninen U; Välttilä S Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):558-63. PubMed ID: 2613390 [TBL] [Abstract][Full Text] [Related]
3. Preliminary pharmacokinetics of the new antitussive compound vadocaine hydrochloride in animals. Mäntylä R; Männistö PT; Vuorela A; Nissinen E Arzneimittelforschung; 1988 Apr; 38(4A):624-7. PubMed ID: 3395399 [TBL] [Abstract][Full Text] [Related]
4. Assessment of the safety margin of vadocaine hydrochloride in man. Karttunen P; Uusitupa M; Helin M; Tukiainen H; Silvasti M Arzneimittelforschung; 1988 Apr; 38(4A):642-6. PubMed ID: 3395404 [TBL] [Abstract][Full Text] [Related]
5. First human studies on the safety and antitussive activity of vadocaine hydrochloride. Karttunen P; Tukiainen H; Uusitupa M; Männistö PT Arzneimittelforschung; 1988 Apr; 38(4A):631-4. PubMed ID: 3395401 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the antitussive effect of vadocaine hydrochloride using citric acid-induced cough in healthy volunteers. Karttunen P Arzneimittelforschung; 1988 Apr; 38(4A):639-41. PubMed ID: 3395403 [TBL] [Abstract][Full Text] [Related]
7. Steady state pharmacokinetics of the new antitussive compound vadocaine hydrochloride. Silvasti M; Karttunen P; Tukiainen H; Mykkänen M; Ottoila P Arzneimittelforschung; 1990 Apr; 40(4):453-6. PubMed ID: 2357246 [TBL] [Abstract][Full Text] [Related]
8. Tissue distribution of the novel antitussive compound vadocaine hydrochloride in white female mice studied by whole-body autoradiography. Vuorela A; Mäntylä R; Männistö PT Arzneimittelforschung; 1988 Apr; 38(4A):628-30. PubMed ID: 3395400 [TBL] [Abstract][Full Text] [Related]
9. Antitussive action of the new anilide derivative vadocaine hydrochloride compared with codeine phosphate in four animal models. Männistö PT; Karttunen P; Lahovaara S; Nissinen E; Davies JE; Algate DR; Baines MW Arzneimittelforschung; 1988 Apr; 38(4A):598-604. PubMed ID: 3395394 [TBL] [Abstract][Full Text] [Related]
10. Studies on the nonspecific central nervous system effects of the novel antitussive compound vadocaine hydrochloride. Karttunen P; Männistö PT; Lahovaara S; Havas A Arzneimittelforschung; 1988 Apr; 38(4A):605-8. PubMed ID: 3395395 [TBL] [Abstract][Full Text] [Related]
11. Comparative studies on the dependence liability of morphine hydrochloride, codeine phosphate and two novel antitussive compounds vadocaine hydrochloride and N-(2',4'-dimethyl-6'-methoxyphenyl)-4-(diethylamine) butanamide hydrochloride in mice. Etemadzadeh E; Ahtee L; Männistö PT Arzneimittelforschung; 1988 Apr; 38(4A):620-3. PubMed ID: 3395398 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and ventilator effects of vadocaine hydrochloride in urethane-anaesthetized rats and guinea-pigs. Paakkari I; Svartström-Fraser M Arzneimittelforschung; 1988 Apr; 38(4A):617-9. PubMed ID: 3395397 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of two opioid antitussives, vadocaine hydrochloride, clobutinol and lidocaine on lung mechanics in guinea-pigs. Salonen RO Arzneimittelforschung; 1988 Apr; 38(4A):609-12. PubMed ID: 3395396 [TBL] [Abstract][Full Text] [Related]
14. Relative bioavailability of different butamirate citrate preparations after single dose oral administration to 18 healthy volunteers. Bohner H; Janiak PS; Nitsche V; Eichinger A; Schütz H Int J Clin Pharmacol Ther; 1997 Mar; 35(3):117-22. PubMed ID: 9089001 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers. Russell T; Stoltz M; Weir S Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study. Zhao RK; Cheng G; Tang J; Song J; Peng WX Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia. Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease. Smith WB; Dowell JA; Pratt RD Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688 [TBL] [Abstract][Full Text] [Related]
19. Single oral dose safety, tolerability, and pharmacokinetics of PNU-96391 in healthy volunteers. Rodríguez CA; Azie NE; Adams G; Donaldson K; Francom SF; Staton BA; Bombardt PA J Clin Pharmacol; 2004 Mar; 44(3):276-83. PubMed ID: 14973308 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol. Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]